Contraindications to Home Sleep Apnea Testing
Home sleep apnea testing (HSAT) should NOT be used in patients with significant cardiorespiratory disease, neuromuscular conditions causing respiratory muscle weakness, awake hypoventilation or suspected sleep-related hypoventilation, chronic opioid use, history of stroke, or severe insomnia 1.
Absolute Contraindications (Use Polysomnography Instead)
The 2017 AASM Clinical Practice Guideline provides a STRONG recommendation that polysomnography, rather than HSAT, must be used in the following patient populations:
Medical Comorbidities
- Significant cardiorespiratory disease - This includes congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, or other conditions that increase risk of central sleep apnea or sleep-related hypoxemia 1
- Neuromuscular conditions with potential respiratory muscle weakness (e.g., ALS, muscular dystrophy, myasthenia gravis) 1
- Awake hypoventilation or suspicion of sleep-related hypoventilation 1
- History of stroke or transient ischemic attack 1
- Chronic opioid medication use - These patients are at high risk for central sleep apnea and hypoventilation 1
Sleep Disorders
- Severe insomnia - This interferes with the accuracy of HSAT by reducing total sleep time and potentially causing false-negative results 1
- Suspected non-respiratory sleep disorders requiring evaluation:
- Disorders of central hypersomnolence (narcolepsy, idiopathic hypersomnia)
- Parasomnias
- Sleep-related movement disorders 1
Technical/Environmental Factors
- Environmental or personal factors that preclude adequate acquisition and interpretation of HSAT data 1
Additional Limitations
Patient Selection Criteria
HSAT is appropriate ONLY for "uncomplicated" adult patients with signs and symptoms indicating increased risk of moderate to severe OSA 1. This means:
- Presence of excessive daytime sleepiness PLUS
- At least 2 of the following: habitual loud snoring, witnessed apneas/gasping/choking, or diagnosed hypertension 1
Not for Screening
- HSAT should not be used for general screening of asymptomatic populations 2
- Must be ordered by a physician after face-to-face evaluation (in-person or telemedicine) 2
Clinical Reasoning
The rationale for these contraindications centers on diagnostic accuracy and patient safety. HSAT devices cannot detect:
- Central sleep apnea patterns (no EEG to distinguish sleep stages)
- Sleep-related hypoventilation (limited CO2 monitoring)
- Other sleep disorders that may coexist or mimic OSA
- True sleep time (leading to underestimation of apnea-hypopnea index)
In complicated patients, the risk of false-negative results is unacceptably high, potentially leading to missed diagnoses with serious consequences for morbidity and mortality 1.
Important Caveat
If a single HSAT is negative, inconclusive, or technically inadequate, polysomnography MUST be performed - this is a STRONG recommendation 1. This serves as a safety net, but does not justify using HSAT in contraindicated populations where the likelihood of inadequate testing is predictably high.